About Hepalink
Established in 1998 in Shenzhen, China, Hepalink is a leading multinational biopharmaceutical  company dual-listed in Hong Kong and mainland China. Driven by patient’s unmet needs, Hepalink is striving to fulfill its mission of bringing safe and effective therapies and services to patients around the world.
1998

years

Established in 1998 in Shenzhen
a+h

stocks

Dual-listed in Hong Kong and mainland China
40+

countries and regions

With presence and business operations in over 40 countries and regions around the world